Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Justin Oldham"'
Autor:
Francesco Amati, Anna Stainer, Marco Mantero, Andrea Gramegna, Edoardo Simonetta, Giulia Suigo, Antonio Voza, Anoop M. Nambiar, Umberto Cariboni, Justin Oldham, Philip L. Molyneaux, Paolo Spagnolo, Francesco Blasi, Stefano Aliberti
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 2, p 977 (2022)
Interstitial lung diseases represent a heterogeneous and wide group of diseases in which factors leading to disease initiation and progression are not fully understood. Recent evidence suggests that the lung microbiome might influence the pathogenesi
Externí odkaz:
https://doaj.org/article/2f1dd2d8f7f448d292c60d30141bcf7e
Publikováno v:
Immunology and Allergy Clinics of North America. 43:411-433
Autor:
Gary M. Hunninghake, Jonathan G. Goldin, Michael A. Kadoch, Jonathan A. Kropski, Ivan O. Rosas, Athol U. Wells, Ruchi Yadav, Howard M. Lazarus, Fereidoun G. Abtin, Tamera J. Corte, Joao A. de Andrade, Kerri A. Johannson, Martin R. Kolb, David A. Lynch, Justin M. Oldham, Paolo Spagnolo, Mary E. Strek, Sara Tomassetti, George R. Washko, Eric S. White, Fereidoun Abtin, Katerina Antoniou, Timothy Blackwell, Kevin Brown, Jonathan Chung, Tamera Corte, Bruno Crestani, Peter Crossno, Daniel Culver, Joao de Andrade, Anand Deveraj, Kevin Flaherty, Gunnar Gudmundsson, Hiroto Hatabu, Joe Jacob, Kerri Johansson, Jeff Kanne, Ella Kazerooni, Martin Kolb, David Lynch, Toby Maher, Fernando Martinez, Antonio Morais, Steven D. Nathan, Imre Noth, Justin Oldham, Anna Podolanczuk, Venerino Poletti, Claudia Ravaglia, Elizabetta Renzoni, Luca Richeldi, Geoffrey Rubin, Chris Ryerson, Debasis Sahoo, Rob Suh, Nicola Sverzellati, Dominique Valeyre, Simon Walsh, George Washko
Publikováno v:
Chest. 161:470-482
Background Interstitial lung abnormalities (ILA) may represent undiagnosed early-stage or subclinical interstitial lung disease (ILD). ILAs are often observed incidentally in patients who subsequently develop clinically overt ILD. There is limited in
Autor:
Emily C. O’Brien, Anne S. Hellkamp, Megan L. Neely, Aparna Swaminathan, Shaun Bender, Laurie D. Snyder, Daniel A. Culver, Craig S. Conoscenti, Jamie L. Todd, Scott M. Palmer, Thomas B. Leonard, Wael Asi, Albert Baker, Scott Beegle, John A. Belperio, Rany Condos, Francis Cordova, Joao A.M. de Andrade, Daniel Dilling, Kevin R. Flaherty, Marilyn Glassberg, Mridu Gulati, Kalpalatha Guntupalli, Nishant Gupta, Amy Hajari Case, David Hotchkin, Tristan Huie, Robert Kaner, Hyun Kim, Maryl Kreider, Lisa Lancaster, Joseph Lasky, David Lederer, Doug Lee, Timothy Liesching, Randolph Lipchik, Jason Lobo, Yolanda Mageto, Prema Menon, Lake Morrison, Andrew Namen, Justin Oldham, Rishi Raj, Murali Ramaswamy, Tonya Russell, Paul Sachs, Zeenat Safdar, Barry Sigal, Leann Silhan, Mary Strek, Sally Suliman, Jeremy Tabak, Rajat Walia, Timothy P. Whelan
Publikováno v:
Chest. 157:1188-1198
Background Limited data are available on the association between clinically measured disease severity markers and quality of life (QOL) in idiopathic pulmonary fibrosis (IPF). The study examined the associations between objective disease severity met
Autor:
Hernan Fainberg, Justin Oldham, Philip Molyneaux, Richard Allen, Luke Kraven, William Fahy, Joanne Porte, Rebecca Braybrooke, Gauri Saini, Morten Karsdal, Diane Leeming, Isaac Triguero, Eunice Oballa, Athol Wells, Elisabetta Renzoni, Louise Wain, Imre Noth, Toby Maher, Iain Stewart, Gisli Jenkins
Publikováno v:
SSRN Electronic Journal.
Autor:
David C. Yang, Ji‐Min Li, Jihao Xu, Justin Oldham, Sem H. Phan, Jerold A. Last, Reen Wu, Ching‐Hsien Chen
Publikováno v:
FASEB J
Targeting activated fibroblasts, including myofibroblast differentiation, has emerged as a key therapeutic strategy in patients with idiopathic pulmonary fibrosis (IPF). However, there is no available therapy capable of selectively eradicating myofib
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
Autor:
Margaret L. Salisbury, Craig S. Conoscenti, Daniel A. Culver, Eric Yow, Megan L. Neely, Shaun Bender, Nadine Hartmann, Scott M. Palmer, Thomas B. Leonard, Albert Baker, Scott Beegle, John Belperio, Rany Condos, Francis Cordova, Daniel Dilling, John Fitzgerald, Kevin R. Flaherty, Kevin Gibson, Mridu Gulati, Kalpalatha Guntupalli, Nishant Gupta, Amy Hajari Case, David Hotchkin, Tristan Huie, Robert Kaner, Hyun Kim, Lisa Lancaster, Joseph A. Lasky, Doug Lee, Timothy Liesching, Randolph Lipchik, Jason Lobo, Tracy Luckhardt (formerly Joao de Andrade), Yolanda Mageto, Numaan Malik, Prema Menon, Lake Morrison, Andrew Namen, Justin Oldham, Tessy Paul, Anna Podolanczuk, Mary Porteous, Rishi Raj, Murali Ramaswamy, Tonya Russell, Paul Sachs, Zeenat Safdar, Shirin Shafazand, Ather Siddiqi, Barry Sigal, Mary Strek, Sally Suliman, Jeremy Tabak, Rajat Walia, Timothy Whelan
Publikováno v:
Annals of the American Thoracic Society
Rationale Two antifibrotic medications, nintedanib and pirfenidone, have been approved for the treatment of idiopathic pulmonary fibrosis (IPF) in the US. Few data have been published on the use of these medications in clinical practice. Objective To
Autor:
Amir A Zeki, Justin Oldham, Machelle Wilson, Olga Fortenko, Vishal Goyal, Michael Last, Andrew Last, Ayan Patel, Jerold A Last, Nicholas J Kenyon
Publikováno v:
BMJ open, vol 3, iss 8
Zeki, AA; Oldham, J; Wilson, M; Fortenko, O; Goyal, V; Last, M; et al.(2013). Statin use and asthma control in patients with severe asthma. BMJ Open, 3(8). doi: 10.1136/bmjopen-2013-003314. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/3v9823bv
BMJ Open
Zeki, AA; Oldham, J; Wilson, M; Fortenko, O; Goyal, V; Last, M; et al.(2013). Statin use and asthma control in patients with severe asthma. BMJ Open, 3(8). doi: 10.1136/bmjopen-2013-003314. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/3v9823bv
BMJ Open
Objectives: We hypothesised that severe asthmatics taking a statin drug, in addition to inhaled corticosteroids/long-acting β-agonist inhaler therapy, would have better asthma symptom control and improved lung function compared to their controls. St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fed7064ea95e026b1cb0ce999c1f27
https://escholarship.org/uc/item/3v9823bv
https://escholarship.org/uc/item/3v9823bv
Autor:
Amir A. Zeki, Justin Oldham, Olga Fortenko, Vishal Goyal, Michael Last, Jerold Last, Andrew Last, Nicholas J. Kenyon
Publikováno v:
D21. ASTHMA THERAPY: NEW TARGETS, NEW TRICKS.
Publikováno v:
B39. CASE REPORTS IN INTERSTITIAL LUNG DISEASE AND MORE I.